or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    UL D 0.14 2.75
    NVS F 0.74 2.43
    CNI F 2.21 1.27
    MFG A 2.24 1.18
    TD D -0.07 0.55
    HSBH B 0.65 0.16

    Represented by ETF Holdings

    Keywords: Asset Management Services Bank Banking Investment Banking Active Pharmaceutical Ingredients Advisory Services American Depositary Receipt Animal Health Antibiotics Asset And Liability Management Asset Management Automated Banking Automated Banking Machines Automotive Products Banking Solutions Biotechnology Blood Test Cash Management Chemical Cleaning Products
    Industries: Banks - Global Banks - Regional - Asia Drug Manufacturers - Major Household & Personal Products Railroads

    Recent News for FlexShares Developed Markets ex-US Quality Low Volatility Index Fund & its Holdings

    Date Stock Title
    Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
    Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
    Nov 21 TD TD Asset Management Inc. Announces Estimated Annual Reinvested Distributions for TD ETFs
    Nov 21 UL Unilever silent amid talk private-equity sale of ice cream off table
    Nov 21 NVS Novartis raises mid-term sales guidance
    Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
    Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
    Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
    Nov 20 UL Unilever ends plans to sell ice cream business to private equity - FT
    Nov 19 TD TD Bank's Annual Survey Reveals Holiday Shoppers This Year Plan to Trim Spending & Avoid Overspending
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 UL Ben & Jerry’s sues parent company Unilever for stifling its stance on Gaza
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
    Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
    Nov 17 MFG Mizuho Financial Group, Inc. 2024 Q2 - Results - Earnings Call Presentation
    Nov 17 MFG Mizuho Financial Group, Inc. (MFG) Q2 2024 Results - Earnings Call Transcript
    Nov 16 UL Key deals this week: Exxon, Unilever, Cardinal Health, Charter Communications and more
    The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Northern Trust Developed Markets ex-US Quality Low Volatility IndexSM. The underlying index is designed to reflect the performance of a selection of companies that, in aggregate, possess lower overall absolute volatility characteristics relative to a broad universe of securities domiciled in developed market countries, excluding the U.S. The fund will invest at least 80% of its total assets in the securities of the underlying index and in ADRs and GDRs based on the securities in the underlying index. It is non-diversified.
    Index Fund Stock Market Index Technical Analysis Volatility VIX
    Back to the Main QLVD Page...